Association between S100A12 and risk of peripheral arterial disease in patients with dyslipidemia: a cross-sectional study
{{output}}
Objective: S100A12 acts as a pro-inflammatory agent in vivo, with a close relationship with plaque formation in patients with acute coronary syndrome (ACS), end-stage renal disease, and diabetes. Peripheral arterial disease (PAD)... ...
